Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H I GLUECK

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
British Journal of Haematology|August 1, 1985
Agarose gel method: its usefulness in assaying factor VIII inhibitors, evaluating treatment and suggesting a mechanism of action for factor IX concentratesM C Coots, H I Glueck, M A Miller
Thrombosis and Haemostasis|December 23, 1981
The lupus inhibitor: a study of its heterogeneityM C Coots, M A Miller, H I Glueck
American Journal of Hematology|October 1, 1985
Factor VIII inhibitors: in vivo decrease of inhibitory activity during calcium infusionA F Muhleman, H I Glueck, M A Miller, et al.
Archives of Otolaryngology (Chicago, Ill. : 1960)|April 1, 1975
Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease). An electron microscopic study of the vascular lesions before and after therapy with hormonesM G Menefee, H C Flessa, H I Glueck, et al.
Metabolism: Clinical and Experimental|November 1, 1993
Inheritance conjointly contributing to fibrinolysis and hyperlipidemiaC J Glueck, H I Glueck, T Tracy, et al.
The Journal of Laboratory and Clinical Medicine|July 1, 1977
Factors which influence blood platelet migrationR W Lowenhaupt, H I Glueck, M A Miller, et al.
Metabolism: Clinical and Experimental|February 1, 1993
Relationships between lipoprotein(a), lipids, apolipoproteins, basal and stimulated fibrinolytic regulators, and D-dimerC J Glueck, H I Glueck, T Tracy, et al.
Thrombosis and Haemostasis|May 3, 1993
Familial high plasminogen activator inhibitor with hypofibrinolysis, a new pathophysiologic cause of osteonecrosis?C J Glueck, H I Glueck, L Mieczkowski, et al.
The American Journal of the Medical Sciences|May 1, 1994
Beta blockers, Lp(a), hypertension, and reduced basal fibrinolytic activityC J Glueck, H I Glueck, T Hamer, et al.
The Journal of Laboratory and Clinical Medicine|March 1, 1989
A monoclonal immunoglobulin A (kappa) factor VIII:C inhibitor associated with primary amyloidosis: identification and characterizationH I Glueck, M C Coots, M Benson, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
British Journal of Haematology|August 1, 1985
Agarose gel method: its usefulness in assaying factor VIII inhibitors, evaluating treatment and suggesting a mechanism of action for factor IX concentratesM C Coots, H I Glueck, M A Miller
Thrombosis and Haemostasis|December 23, 1981
The lupus inhibitor: a study of its heterogeneityM C Coots, M A Miller, H I Glueck
American Journal of Hematology|October 1, 1985
Factor VIII inhibitors: in vivo decrease of inhibitory activity during calcium infusionA F Muhleman, H I Glueck, M A Miller, et al.
Archives of Otolaryngology (Chicago, Ill. : 1960)|April 1, 1975
Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease). An electron microscopic study of the vascular lesions before and after therapy with hormonesM G Menefee, H C Flessa, H I Glueck, et al.
Metabolism: Clinical and Experimental|November 1, 1993
Inheritance conjointly contributing to fibrinolysis and hyperlipidemiaC J Glueck, H I Glueck, T Tracy, et al.
The Journal of Laboratory and Clinical Medicine|July 1, 1977
Factors which influence blood platelet migrationR W Lowenhaupt, H I Glueck, M A Miller, et al.
Metabolism: Clinical and Experimental|February 1, 1993
Relationships between lipoprotein(a), lipids, apolipoproteins, basal and stimulated fibrinolytic regulators, and D-dimerC J Glueck, H I Glueck, T Tracy, et al.
Thrombosis and Haemostasis|May 3, 1993
Familial high plasminogen activator inhibitor with hypofibrinolysis, a new pathophysiologic cause of osteonecrosis?C J Glueck, H I Glueck, L Mieczkowski, et al.
The American Journal of the Medical Sciences|May 1, 1994
Beta blockers, Lp(a), hypertension, and reduced basal fibrinolytic activityC J Glueck, H I Glueck, T Hamer, et al.
The Journal of Laboratory and Clinical Medicine|March 1, 1989
A monoclonal immunoglobulin A (kappa) factor VIII:C inhibitor associated with primary amyloidosis: identification and characterizationH I Glueck, M C Coots, M Benson, et al.
Pageof 4